New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
about
Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulationsMolecular docking of (5E)-3-(2-aminoethyl)-5-(2- thienylmethylene)-1, 3-thiazolidine-2, 4-dione on HIV-1 reverse transcriptase: novel drug acting on enzyme.Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study.Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors[d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase.Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjectsEmerging anti-HIV drugs.Efavirenz: a review.C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 Reverse Transcriptase: A Fluorine Nuclear Magnetic Resonance Study.Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.Additivity in the analysis and design of HIV protease inhibitors.Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection.Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.Pharmacoeconomics of etravirine.In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).Synthesis of some new benzisothiazolone and benzenesulfonamide derivatives of biological interest starting from saccharin sodium.Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.2-Benzyl-sulfanyl-4-pentyl-6-(phenyl-sulfan-yl)pyrimidine-5-carbonitrile.Nitroimidazoles Part 6. Synthesis, structure and in vitro anti-HIV activity of new 5-substituted piperazinyl-4-nitroimidazole derivatives.Synthesis, biological evaluation and molecular modeling studies of new 2,3-diheteroaryl thiazolidin-4-ones as NNRTIs.The disposition and metabolism of GW695634: a non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS.Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design.Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues.3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
P2860
Q24654012-F176840E-38D5-4451-AFD4-ECDC31382C8FQ30422172-7ABAA1A8-E09E-4FD8-A37C-87582BFD6DD9Q33966485-449E41C3-F3E3-4708-B218-1ADCCA529C09Q33996952-892ABCC4-73F9-40C6-A530-B56F4C7532F4Q34242282-C0BF57E8-9D09-4195-B526-36AF71E4D5FDQ34306474-90BC9161-B6DA-4793-A7B1-9E385C708AD6Q36150601-F3B3BFF1-CF0C-44F8-B770-B1DC2E4E6056Q36787311-204A04D8-C522-4539-A677-FC2BCDEA6A20Q37091525-B3A2910A-6CA6-4E54-8759-5E196DEBFBFEQ37114525-22076A67-2AB0-451C-8E29-15DFB7BD6D88Q37176489-119EAC34-EFF0-4B3B-8DD1-28BDD75EE604Q37275215-D3D3BE3D-4D0B-4DE0-96D5-B7704F627207Q37405054-A59AE9BE-54DD-4742-8C76-A0EA173BD931Q37406001-C895D2A1-EF65-490A-ACF4-889AA425E66DQ37800478-F9CC8B45-A2C4-48A8-8727-96B3BF0AF262Q38012389-53612048-2D11-44F8-971C-32176D994A69Q39095730-A40A900A-67E3-4B07-B26B-D96D00886232Q39635884-D3224329-2A34-4C5B-9ECB-B952A39F8166Q40027780-779B9023-4A74-492C-A63E-BDE93C5467F9Q40073996-A2EBA467-4945-4CF4-B7CB-D5A06F240E6EQ41192235-AA7F00CD-3028-4A20-A898-D3F53AA89D7AQ43104680-D55A7D07-F827-466F-AB1B-879F39480C30Q46037246-50C6661A-0E97-45B8-9CAA-DA370A84C4E4Q51607600-6FECFCC0-ECAD-40A0-8D9B-D9A56F28FA4FQ54645952-761622F3-8CD2-4EB9-B8B3-D0619D82A1C4
P2860
New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@ast
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@en
type
label
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@ast
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@en
prefLabel
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@ast
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@en
P1476
New non-nucleoside reverse tra ...... e treatment of HIV infections.
@en
P2093
Rudi Pauwels
P304
P356
10.1016/J.COPH.2004.07.005
P577
2004-10-01T00:00:00Z